FAM3A
gene geneOn this page
Also known as DXS560S2-19XAP-7
Summary
FAM3A (FAM3 metabolism regulating signaling molecule A, HGNC:13749) is a protein-coding gene on chromosome Xq28, encoding Protein FAM3A (P98173). May act as a defensin against invading fungal microorganisms.
This gene encodes a cytokine-like protein. The expression of this gene may be regulated by peroxisome proliferator-activated receptor gamma, and the encoded protein may be involved in the regulation of glucose and lipid metabolism. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 60343 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 60 total — 1 pathogenic
- MANE Select transcript:
NM_021806
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13749 |
| Approved symbol | FAM3A |
| Name | FAM3 metabolism regulating signaling molecule A |
| Location | Xq28 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DXS560S, 2-19, XAP-7 |
| Ensembl gene | ENSG00000071889 |
| Ensembl biotype | protein_coding |
| OMIM | 300492 |
| Entrez | 60343 |
Gene structure
Transcript identifiers
Ensembl transcripts: 37 — 24 protein_coding, 8 nonsense_mediated_decay, 3 protein_coding_CDS_not_defined, 2 retained_intron
ENST00000322269, ENST00000359889, ENST00000369641, ENST00000369643, ENST00000393572, ENST00000412894, ENST00000416319, ENST00000419205, ENST00000421517, ENST00000426266, ENST00000433619, ENST00000434658, ENST00000440318, ENST00000442929, ENST00000447601, ENST00000449971, ENST00000457212, ENST00000475657, ENST00000492763, ENST00000497506, ENST00000612856, ENST00000621967, ENST00000858755, ENST00000858756, ENST00000858757, ENST00000858758, ENST00000858759, ENST00000858760, ENST00000858761, ENST00000858762, ENST00000858763, ENST00000938531, ENST00000959364, ENST00000959365, ENST00000959366, ENST00000959367, ENST00000959368
RefSeq mRNA: 7 — MANE Select: NM_021806
NM_001171132, NM_001171133, NM_001171134, NM_001282311, NM_001282312, NM_001363822, NM_021806
CCDS: CCDS35453, CCDS55542, CCDS55543, CCDS76060, CCDS87800
Canonical transcript exons
ENST00000447601 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001946741 | 154515760 | 154516232 |
| ENSE00003476225 | 154511848 | 154511871 |
| ENSE00003608059 | 154508289 | 154508347 |
| ENSE00003624095 | 154508474 | 154508597 |
| ENSE00003631195 | 154507811 | 154507861 |
| ENSE00003643891 | 154507203 | 154507329 |
| ENSE00003648699 | 154506171 | 154506906 |
| ENSE00003734672 | 154512823 | 154512936 |
| ENSE00003789744 | 154507406 | 154507490 |
Expression profiles
Bgee: expression breadth ubiquitous, 262 present calls, max score 96.52.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 24.1297 / max 130.9571, expressed in 1816 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 201039 | 20.9930 | 1813 |
| 201038 | 3.1367 | 1402 |
Top tissues by expression
285 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lower esophagus mucosa | UBERON:0035834 | 96.52 | gold quality |
| apex of heart | UBERON:0002098 | 96.43 | gold quality |
| left ovary | UBERON:0002119 | 95.57 | gold quality |
| adenohypophysis | UBERON:0002196 | 95.41 | gold quality |
| right ovary | UBERON:0002118 | 95.27 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 95.19 | gold quality |
| mucosa of stomach | UBERON:0001199 | 95.00 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 94.88 | gold quality |
| endocervix | UBERON:0000458 | 94.78 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 94.48 | gold quality |
| right lobe of liver | UBERON:0001114 | 94.45 | gold quality |
| body of pancreas | UBERON:0001150 | 94.33 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 94.30 | gold quality |
| pituitary gland | UBERON:0000007 | 94.11 | gold quality |
| right atrium auricular region | UBERON:0006631 | 94.09 | gold quality |
| ectocervix | UBERON:0012249 | 93.96 | gold quality |
| spinal cord | UBERON:0002240 | 93.46 | gold quality |
| body of stomach | UBERON:0001161 | 93.43 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 93.43 | gold quality |
| transverse colon | UBERON:0001157 | 93.40 | gold quality |
| body of uterus | UBERON:0009853 | 93.40 | gold quality |
| right frontal lobe | UBERON:0002810 | 93.24 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 93.23 | gold quality |
| thyroid gland | UBERON:0002046 | 93.18 | gold quality |
| right uterine tube | UBERON:0001302 | 93.05 | gold quality |
| left uterine tube | UBERON:0001303 | 93.03 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 93.01 | gold quality |
| left adrenal gland | UBERON:0001234 | 92.97 | gold quality |
| metanephros cortex | UBERON:0010533 | 92.87 | gold quality |
| lower esophagus | UBERON:0013473 | 92.85 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 8.25 |
| E-HCAD-5 | no | 2.29 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): PPARA, PPARG
miRNA regulators (miRDB)
16 targeting FAM3A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-6757-3P | 99.63 | 66.88 | 1089 |
| HSA-MIR-4477A | 98.83 | 69.75 | 2952 |
| HSA-MIR-1227-5P | 98.65 | 65.32 | 1549 |
| HSA-MIR-484 | 98.16 | 66.92 | 1074 |
| HSA-MIR-3155A | 98.16 | 66.09 | 965 |
| HSA-MIR-3155B | 98.16 | 66.09 | 965 |
| HSA-MIR-6893-3P | 97.79 | 64.91 | 1238 |
| HSA-MIR-7154-3P | 97.65 | 65.02 | 985 |
| HSA-MIR-6890-3P | 97.50 | 65.71 | 997 |
| HSA-MIR-10398-5P | 97.12 | 64.94 | 1051 |
| HSA-MIR-370-3P | 97.09 | 64.92 | 1221 |
| HSA-MIR-6762-5P | 96.55 | 64.62 | 972 |
| HSA-MIR-6845-5P | 96.55 | 64.65 | 969 |
Literature-anchored findings (GeneRIF, showing 12)
- Expressed prominently in the vascular endothelium, particularly capillaries, also in islets of Langerhans. (PMID:12160727)
- In the present study, we report a putative human homologue of the antimicrobial Drosophila-derived drosomycin, designated drosomycin-like defensin (DLD), with specific antifungal activity. (PMID:18212107)
- Upregulation of FAM3A by PPARgamma activation is correlated with increased pAkt level in liver cells (PMID:23562554)
- FAM3A plays crucial roles in the regulation of glucose and lipid metabolism in the liver, where it activates the PI3K-Akt signaling pathway by way of a Ca(2+) /CaM-dependent mechanism (PMID:24806753)
- These results suggest that C/EBPbeta plays an important role in regulating FAM3A promoter activity and FAM3A inhibits adipocyte differentiation. (PMID:27688071)
- Fam3A may regulate high glucose-induced reactive oxygen species production in HUVECs via the p38 MAPK signaling pathway. (PMID:29532774)
- our data demonstrate that FAM3A positively regulates angiogenesis through activation of VEGFA transcription, suggesting that FAM3A may constitute a novel molecular therapeutic target for ischaemic vascular disease. (PMID:31000420)
- In this case prenatal ultrasound images were suggestive of a serious but non-lethal skeletal dysplasia. Due to the uncertain prognosis the parents were offered Whole Exome Sequencing (WES), which identified a specific gene mutation in the FAMIIIa gene (PMID:31910817)
- FAM3A mediates the phenotypic switch of human aortic smooth muscle cells stimulated with oxidised low-density lipoprotein by influencing the PI3K-AKT pathway. (PMID:37474885)
- FAM3A plays a key role in protecting against tubular cell pyroptosis and acute kidney injury. (PMID:38875957)
- PANX1-mediated ATP release confers FAM3A’s suppression effects on hepatic gluconeogenesis and lipogenesis. (PMID:38937853)
- Circulating extracellular vesicle-derived miR-1299 disrupts hepatic glucose homeostasis by targeting the STAT3/FAM3A axis in gestational diabetes mellitus. (PMID:39182087)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | fam3a | ENSDARG00000070675 |
| mus_musculus | Fam3a | ENSMUSG00000031399 |
| rattus_norvegicus | Fam3a | ENSRNOG00000060623 |
| caenorhabditis_elegans | WBGENE00019786 |
Paralogs (3): FAM3B (ENSG00000183844), FAM3C (ENSG00000196937), FAM3D (ENSG00000198643)
Protein
Protein identifiers
Protein FAM3A — P98173 (reviewed: P98173)
Alternative names: Cytokine-like protein 2-19
All UniProt accessions (10): P98173, A6QRH7, A6QRH8, D3DWX8, F8WB47, F8WD39, F8WEM7, F8WEW8, Q5HY75, Q9BU27
UniProt curated annotations — full annotation on UniProt →
Function. May act as a defensin against invading fungal microorganisms.
Subcellular location. Secreted.
Tissue specificity. In similar amounts in testis, pancreas, adrenal, placenta, brain, fetal brain, liver, kidney, skeletal muscle and heart.
Similarity. Belongs to the FAM3 family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P98173-1 | 1 | yes |
| P98173-2 | 2 | |
| P98173-3 | 3 |
RefSeq proteins (7): NP_001164603, NP_001164604, NP_001164605, NP_001269240, NP_001269241, NP_001350751, NP_068578* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR039220 | FAM3 | Family |
| IPR039475 | ILEI_FAM3C | Domain |
| IPR039477 | ILEI/PANDER_dom | Domain |
Pfam: PF15711
UniProt features (9 total): disulfide bond 2, splice variant 2, sequence variant 2, signal peptide 1, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P98173-F1 | 89.05 | 0.74 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (2): 59–87, 65–222
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 145 (showing top):
GSE45365_NK_CELL_VS_CD11B_DC_UP, GOBP_ANTIMICROBIAL_HUMORAL_RESPONSE, GOBP_INSULIN_SECRETION, GOBP_NEGATIVE_REGULATION_OF_INNATE_IMMUNE_RESPONSE, GOBP_REGULATION_OF_HORMONE_LEVELS, GOBP_HORMONE_TRANSPORT, DARWICHE_SKIN_TUMOR_PROMOTER_DN, DARWICHE_PAPILLOMA_RISK_LOW_DN, DARWICHE_PAPILLOMA_RISK_HIGH_DN, GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS, DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN, GOBP_NUCLEOSIDE_PHOSPHATE_BIOSYNTHETIC_PROCESS, GOBP_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS, GOBP_CARBOHYDRATE_DERIVATIVE_METABOLIC_PROCESS, GOBP_CELL_CELL_SIGNALING
GO Biological Process (10): glucose metabolic process (GO:0006006), ATP biosynthetic process (GO:0006754), mitochondrion organization (GO:0007005), response to glucose (GO:0009749), gene expression (GO:0010467), antifungal humoral response (GO:0019732), insulin secretion (GO:0030073), calcium ion homeostasis (GO:0055074), antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844), negative regulation of antifungal innate immune response (GO:1905035)
GO Molecular Function (2): carbohydrate binding (GO:0030246), protein binding (GO:0005515)
GO Cellular Component (3): obsolete extracellular space (GO:0005615), extracellular region (GO:0005576), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| antimicrobial humoral response | 2 |
| binding | 2 |
| cellular anatomical structure | 2 |
| hexose metabolic process | 1 |
| purine ribonucleotide biosynthetic process | 1 |
| purine ribonucleoside triphosphate biosynthetic process | 1 |
| ATP metabolic process | 1 |
| organelle organization | 1 |
| response to hexose | 1 |
| macromolecule biosynthetic process | 1 |
| defense response to fungus | 1 |
| protein secretion | 1 |
| peptide hormone secretion | 1 |
| monoatomic cation homeostasis | 1 |
| inorganic ion homeostasis | 1 |
| negative regulation of innate immune response | 1 |
| antifungal innate immune response | 1 |
| regulation of antifungal innate immune response | 1 |
Protein interactions and networks
STRING
368 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FAM3A | C3orf18 | Q9UK00 | 492 |
| FAM3A | ABHD1 | Q96SE0 | 478 |
| FAM3A | UNC45A | Q9H3U1 | 447 |
| FAM3A | HEATR1 | Q9H583 | 443 |
| FAM3A | UNC45B | Q8IWX7 | 426 |
| FAM3A | FAM20B | O75063 | 348 |
| FAM3A | P0DMU3 | P0DMU3 | 331 |
| FAM3A | CCDC22 | O60826 | 328 |
| FAM3A | NXPE2 | Q96DL1 | 290 |
| FAM3A | TXNDC15 | Q96J42 | 286 |
| FAM3A | GMPPA | Q96IJ6 | 284 |
| FAM3A | KARS1 | Q15046 | 274 |
| FAM3A | NFE2 | Q16621 | 270 |
| FAM3A | PYURF | Q96I23 | 248 |
| FAM3A | SH2D5 | Q6ZV89 | 247 |
IntAct
13 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FAM3A | CREB3 | psi-mi:“MI:0915”(physical association) | 0.370 |
| PACRGL | FAM3A | psi-mi:“MI:0915”(physical association) | 0.370 |
| ORF47 | ZZEF1 | psi-mi:“MI:0914”(association) | 0.350 |
| B3GNT2 | NDUFA10 | psi-mi:“MI:0914”(association) | 0.350 |
| B3GNT2 | PDLIM1 | psi-mi:“MI:0914”(association) | 0.350 |
| FAM3A | NMU | psi-mi:“MI:0914”(association) | 0.350 |
| B3GNT2 | FAM3A | psi-mi:“MI:0914”(association) | 0.350 |
| SLC30A7 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC3A1 | ILVBL | psi-mi:“MI:0914”(association) | 0.350 |
| SLC47A1 | PLOD2 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC9A9 | PODXL | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (30): FAM3A (Two-hybrid), FAM3A (Two-hybrid), CLEC7A (Two-hybrid), MAL2 (Two-hybrid), FAM3A (Affinity Capture-MS), FAM3A (Two-hybrid), FAM3A (Two-hybrid), FAM3A (Affinity Capture-MS), FAM3A (Affinity Capture-MS), FAM3A (Affinity Capture-MS), FAM3A (Affinity Capture-RNA), FAM3A (Affinity Capture-MS), NMU (Affinity Capture-MS), HS6ST2 (Affinity Capture-MS), FAM3A (Affinity Capture-MS)
ESM2 similar proteins: A0A1B0GVV1, A2AFS3, A4IFL2, B1AZA5, D4ABL6, E9PV86, M0R7X9, O73612, P01134, P01135, P01344, P07456, P10764, P23695, P33717, P48030, P51459, P52799, P52800, P55244, P98135, P98173, Q06922, Q0VBP7, Q17QD6, Q2YDG0, Q3KRC4, Q3SXP7, Q3ZBS2, Q4V7F2, Q5EA46, Q5R5C3, Q6DN14, Q6NW40, Q6ZN54, Q7Z5A7, Q7Z6G3, Q7Z6J6, Q8K3J9, Q8NBT3
Diamond homologs: A5PKI3, B0BLS9, P58499, P97805, P98173, Q5R5C3, Q6GQC1, Q7ZYY4, Q810F4, Q8BI06, Q8WUJ3, Q91VU0, Q92520, Q96BQ1, Q9D309, Q9D8T0, Q5EAB6, Q5RCB9, Q5XIN7, Q8WZA1, Q91X88, A3KPQ7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
60 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 11 |
| Likely benign | 4 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 58008 | GRCh38/hg38 Xq28(chrX:153296806-155699618)x1 | Pathogenic |
SpliceAI
1702 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:154506903:CGTG:C | acceptor_gain | 1.0000 |
| X:154506904:GTG:G | acceptor_gain | 1.0000 |
| X:154506905:TG:T | acceptor_gain | 1.0000 |
| X:154506905:TGCTG:T | acceptor_loss | 1.0000 |
| X:154506906:GCTGT:G | acceptor_loss | 1.0000 |
| X:154506907:C:CC | acceptor_gain | 1.0000 |
| X:154506907:CT:C | acceptor_loss | 1.0000 |
| X:154506909:G:C | acceptor_gain | 1.0000 |
| X:154507199:ATACC:A | donor_loss | 1.0000 |
| X:154507200:TA:T | donor_loss | 1.0000 |
| X:154507201:A:T | donor_loss | 1.0000 |
| X:154507202:CCTG:C | donor_gain | 1.0000 |
| X:154507254:G:C | donor_gain | 1.0000 |
| X:154507325:TCATC:T | acceptor_gain | 1.0000 |
| X:154507326:CATC:C | acceptor_gain | 1.0000 |
| X:154507326:CATCC:C | acceptor_gain | 1.0000 |
| X:154507328:TC:T | acceptor_gain | 1.0000 |
| X:154507329:CC:C | acceptor_gain | 1.0000 |
| X:154507330:C:CC | acceptor_gain | 1.0000 |
| X:154507330:C:CG | acceptor_loss | 1.0000 |
| X:154507400:ACCT:A | donor_loss | 1.0000 |
| X:154507403:TA:T | donor_loss | 1.0000 |
| X:154507404:A:AC | donor_gain | 1.0000 |
| X:154507404:AC:A | donor_loss | 1.0000 |
| X:154507405:C:CC | donor_gain | 1.0000 |
| X:154507486:GACAT:G | acceptor_gain | 1.0000 |
| X:154507488:CAT:C | acceptor_gain | 1.0000 |
| X:154507489:AT:A | acceptor_gain | 1.0000 |
| X:154507490:TCTG:T | acceptor_loss | 1.0000 |
| X:154507491:C:CA | acceptor_loss | 1.0000 |
AlphaMissense
1523 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:154506865:C:A | W213C | 1.000 |
| X:154506865:C:G | W213C | 1.000 |
| X:154506867:A:G | W213R | 1.000 |
| X:154506867:A:T | W213R | 1.000 |
| X:154506875:T:C | Y210C | 1.000 |
| X:154507251:C:A | W183C | 1.000 |
| X:154507251:C:G | W183C | 1.000 |
| X:154507253:A:G | W183R | 1.000 |
| X:154507253:A:T | W183R | 1.000 |
| X:154508312:C:T | G104E | 1.000 |
| X:154508519:C:T | G77E | 1.000 |
| X:154508520:C:A | G77W | 1.000 |
| X:154506839:C:G | C222S | 0.999 |
| X:154506840:A:G | C222R | 0.999 |
| X:154506840:A:T | C222S | 0.999 |
| X:154506863:G:T | P214H | 0.999 |
| X:154506876:A:G | Y210H | 0.999 |
| X:154507243:A:T | V186D | 0.999 |
| X:154507246:A:G | F185S | 0.999 |
| X:154507254:G:C | S182R | 0.999 |
| X:154507254:G:T | S182R | 0.999 |
| X:154507256:T:G | S182R | 0.999 |
| X:154507258:T:A | D181V | 0.999 |
| X:154507261:C:G | R180P | 0.999 |
| X:154507263:G:C | F179L | 0.999 |
| X:154507263:G:T | F179L | 0.999 |
| X:154507265:A:G | F179L | 0.999 |
| X:154507287:G:C | S171R | 0.999 |
| X:154507287:G:T | S171R | 0.999 |
| X:154507289:T:G | S171R | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000343705 (X:154515305 C>T), RS1001789813 (X:154506474 G>A), RS1002018459 (X:154513561 C>T), RS1002516830 (X:154514075 G>A), RS1002679643 (X:154509568 A>G), RS1002831992 (X:154510196 G>A), RS1002950949 (X:154517912 G>A), RS1003465607 (X:154505743 G>A), RS1003787848 (X:154511965 G>A,C), RS1004099446 (X:154511567 G>C), RS1004501440 (X:154505908 A>T), RS1004579687 (X:154506017 C>A,T), RS1005040791 (X:154511985 G>A,T), RS1005706335 (X:154516773 C>T), RS1006694169 (X:154507117 C>T)
Disease associations
OMIM: gene MIM:300492 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001873_9 | Red blood cell traits | 4.000000e-14 |
| GCST003122_2 | Hemoglobin levels | 3.000000e-11 |
| GCST90002381_505 | Eosinophil count | 2.000000e-09 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004509 | hemoglobin measurement |
| EFO:0007629 | hemoglobin A1 measurement |
| EFO:0004842 | eosinophil count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases abundance, increases expression | 2 |
| Arsenic | affects methylation, increases abundance, increases expression | 2 |
| bisphenol A | decreases expression | 1 |
| potassium chromate(VI) | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Hydralazine | affects cotreatment, increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Selenium | affects cotreatment, decreases expression, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Valproic Acid | affects cotreatment, increases expression | 1 |
| Vitamin E | affects cotreatment, decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.